HEADER TRANSCRIPTION 20-DEC-12 4II6 OBSLTE 11-FEB-15 4II6 4WVD TITLE IDENTIFICATION OF A NOVEL FXR LIGAND THAT REGULATES METABOLISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR COREPRESSOR 1; COMPND 3 CHAIN: C, D; COMPND 4 FRAGMENT: UNP RESIDUES 2259-2275; COMPND 5 SYNONYM: N-COR, N-COR1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BILE ACID RECEPTOR; COMPND 9 CHAIN: A, B; COMPND 10 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 258-473; COMPND 11 SYNONYM: FARNESOID X-ACTIVATED RECEPTOR, FARNESOL RECEPTOR HRR-1, COMPND 12 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4, RETINOID X RECEPTOR- COMPND 13 INTERACTING PROTEIN 14, RXR-INTERACTING PROTEIN 14; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: SYNTHETIC CONSTRUCT; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 GENE: NR1H4, BAR, FXR, HRR1, RIP14; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PET24A KEYWDS AF-2 HELIX, LIGAND BINDING POCKET, THREE-LAYER HELICAL SANDWICH, KEYWDS 2 TRANSCRIPTION REGULATOR FXR, BAR, NR1H4, BILE ACID RECEPTOR, NHR, KEYWDS 3 NUCLEAR RECEPTOR, COREPRESSOR, TRANSCRIPTION, TRANSCRIPTION KEYWDS 4 REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR R.WANG,Y.LI REVDAT 3 11-FEB-15 4II6 1 OBSLTE REVDAT 2 18-SEP-13 4II6 1 JRNL REVDAT 1 12-JUN-13 4II6 0 JRNL AUTH L.JIN,X.FENG,H.RONG,Z.PAN,Y.INABA,L.QIU,W.ZHENG,S.LIN, JRNL AUTH 2 R.WANG,Z.WANG,S.WANG,H.LIU,S.LI,W.XIE,Y.LI JRNL TITL THE ANTIPARASITIC DRUG IVERMECTIN IS A NOVEL FXR LIGAND THAT JRNL TITL 2 REGULATES METABOLISM JRNL REF NAT COMMUN V. 4 1937 2013 JRNL REFN ESSN 2041-1723 JRNL PMID 23728580 JRNL DOI 10.1038/NCOMMS2924 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 15531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 819 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 971 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.4450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3511 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.21000 REMARK 3 B22 (A**2) : -0.50000 REMARK 3 B33 (A**2) : 0.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.540 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.436 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.350 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.686 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.908 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.880 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3724 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5051 ; 2.008 ; 2.011 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 451 ; 7.365 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 161 ;40.947 ;25.404 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 607 ;23.288 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;19.584 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 604 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2716 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4II6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-JAN-13. REMARK 100 THE RCSB ID CODE IS RCSB076782. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0050 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32410 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 38.597 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM HEPES PH7.0, 3.5M SODIUM FORMATE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.50400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.50900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 80.87950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.50900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.50400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 80.87950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.50400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 80.87950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 84.50900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 80.87950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.50400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 84.50900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 601 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 278 REMARK 465 GLU B 244 REMARK 465 GLY B 356 REMARK 465 ILE B 357 REMARK 465 ARG B 455 REMARK 465 VAL B 456 REMARK 465 ASN B 457 REMARK 465 ASP B 458 REMARK 465 HIS B 459 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU C2264 CG CD OE1 OE2 REMARK 470 LYS C2269 CG CD CE NZ REMARK 470 ILE A 269 CG1 CG2 CD1 REMARK 470 THR A 270 OG1 CG2 REMARK 470 LYS A 272 CG CD CE NZ REMARK 470 ILE A 273 CG1 CG2 CD1 REMARK 470 LEU A 274 CG CD1 CD2 REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLU A 289 CG CD OE1 OE2 REMARK 470 LYS A 304 CG CD CE NZ REMARK 470 LYS A 338 CG CD CE NZ REMARK 470 ARG A 351 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 353 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 359 CG OD1 OD2 REMARK 470 TYR A 369 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 PHE A 443 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS A 446 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 449 CG CD OE1 OE2 REMARK 470 MET A 452 CG SD CE REMARK 470 ARG A 455 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 262 CG CD CE NZ REMARK 470 GLN B 263 CG CD OE1 NE2 REMARK 470 ARG B 264 CG CD NE CZ NH1 NH2 REMARK 470 MET B 265 CG SD CE REMARK 470 PRO B 266 CG CD REMARK 470 GLN B 267 CG CD OE1 NE2 REMARK 470 ILE B 269 CG1 CG2 CD1 REMARK 470 THR B 270 OG1 CG2 REMARK 470 LYS B 272 CE NZ REMARK 470 ILE B 273 CG1 CG2 CD1 REMARK 470 LEU B 274 CG CD1 CD2 REMARK 470 GLU B 277 CG CD OE1 OE2 REMARK 470 PHE B 278 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 285 CG CD1 CD2 REMARK 470 GLU B 289 CG CD OE1 OE2 REMARK 470 GLU B 314 CG CD OE1 OE2 REMARK 470 LYS B 338 CG CD CE NZ REMARK 470 ASP B 346 CG OD1 OD2 REMARK 470 LEU B 348 CG CD1 CD2 REMARK 470 GLU B 349 CG CD OE1 OE2 REMARK 470 ARG B 351 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 352 CG1 CG2 CD1 REMARK 470 ARG B 353 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 359 CG OD1 OD2 REMARK 470 ILE B 362 CG1 CG2 CD1 REMARK 470 LYS B 370 CG CD CE NZ REMARK 470 LYS B 399 CG CD CE NZ REMARK 470 GLU B 409 CG CD OE1 OE2 REMARK 470 LYS B 417 CG CD CE NZ REMARK 470 LYS B 420 CG CD CE NZ REMARK 470 HIS B 446 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 447 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 FMT B 501 O1 FMT B 502 2.01 REMARK 500 O SER A 345 N LEU A 347 2.04 REMARK 500 N SER A 355 N ILE A 357 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS B 254 CG HIS B 254 CD2 0.054 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 451 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C2260 66.23 163.64 REMARK 500 LEU C2261 -97.52 -73.09 REMARK 500 LEU C2263 -74.67 -58.74 REMARK 500 GLU C2264 -29.10 -36.55 REMARK 500 MET C2272 -86.30 -156.18 REMARK 500 SER C2274 -16.45 -42.97 REMARK 500 PRO A 247 -39.61 -32.68 REMARK 500 LYS A 262 1.33 -58.88 REMARK 500 ARG A 264 -123.27 -133.22 REMARK 500 ILE A 273 -109.54 -68.03 REMARK 500 GLU A 276 -158.42 -138.73 REMARK 500 ALA A 280 -58.68 -153.48 REMARK 500 GLU A 282 -83.36 -69.93 REMARK 500 ASN A 283 -44.89 -14.99 REMARK 500 THR A 288 -37.67 -38.69 REMARK 500 ALA A 291 -82.88 -61.79 REMARK 500 THR A 292 -52.85 -10.61 REMARK 500 PRO A 306 98.84 -44.90 REMARK 500 ASP A 312 -142.70 -59.28 REMARK 500 HIS A 313 -52.64 -130.08 REMARK 500 PHE A 336 -19.60 -34.81 REMARK 500 ASN A 337 12.13 -152.07 REMARK 500 LYS A 339 -170.00 -69.51 REMARK 500 LEU A 340 144.82 58.13 REMARK 500 PRO A 341 -88.46 -62.03 REMARK 500 HIS A 344 104.09 -26.63 REMARK 500 SER A 345 49.61 -164.33 REMARK 500 ASP A 346 -35.57 45.37 REMARK 500 LEU A 347 17.60 41.96 REMARK 500 GLU A 349 -17.61 -48.24 REMARK 500 GLU A 350 -6.23 -56.36 REMARK 500 ILE A 352 104.14 -165.09 REMARK 500 ASN A 354 140.34 -28.99 REMARK 500 ILE A 357 93.41 -31.63 REMARK 500 SER A 358 -123.58 -113.16 REMARK 500 MET A 365 -26.62 -37.21 REMARK 500 PRO A 393 2.34 -68.93 REMARK 500 TYR A 397 -7.96 92.44 REMARK 500 ASP A 400 73.60 -118.77 REMARK 500 GLN A 423 78.72 -174.14 REMARK 500 ASN A 444 13.59 -67.13 REMARK 500 GLU A 449 84.40 -150.47 REMARK 500 MET A 450 30.15 -94.09 REMARK 500 MET A 452 -105.56 74.33 REMARK 500 SER A 453 153.25 150.43 REMARK 500 TRP A 454 95.83 52.49 REMARK 500 ARG A 455 85.44 81.91 REMARK 500 VAL A 456 -156.31 -100.63 REMARK 500 ASN A 457 53.69 -26.72 REMARK 500 ASP A 458 70.80 45.18 REMARK 500 REMARK 500 THIS ENTRY HAS 84 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 354 SER A 355 148.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LEU C2261 24.0 L L OUTSIDE RANGE REMARK 500 ASN A 457 23.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2301 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH D2302 DISTANCE = 6.48 ANGSTROMS REMARK 525 HOH D2303 DISTANCE = 6.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVM A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IVM B 505 DBREF 4II6 C 2259 2275 UNP O75376 NCOR1_HUMAN 2259 2275 DBREF 4II6 A 244 459 UNP Q96RI1 NR1H4_HUMAN 258 473 DBREF 4II6 D 2259 2275 UNP O75376 NCOR1_HUMAN 2259 2275 DBREF 4II6 B 244 459 UNP Q96RI1 NR1H4_HUMAN 258 473 SEQRES 1 C 17 SER ASN LEU GLY LEU GLU ASP ILE ILE ARG LYS ALA LEU SEQRES 2 C 17 MET GLY SER PHE SEQRES 1 A 216 GLU LEU THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE SEQRES 2 A 216 MET ASP SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE SEQRES 3 A 216 THR ASN LYS ILE LEU LYS GLU GLU PHE SER ALA GLU GLU SEQRES 4 A 216 ASN PHE LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL SEQRES 5 A 216 GLN VAL LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE SEQRES 6 A 216 GLN THR LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS SEQRES 7 A 216 GLY SER ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU SEQRES 8 A 216 ILE PHE ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU SEQRES 9 A 216 LEU GLU GLU ARG ILE ARG ASN SER GLY ILE SER ASP GLU SEQRES 10 A 216 TYR ILE THR PRO MET PHE SER PHE TYR LYS SER ILE GLY SEQRES 11 A 216 GLU LEU LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR SEQRES 12 A 216 ALA ILE VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS SEQRES 13 A 216 ASP ARG GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU SEQRES 14 A 216 ASP VAL LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU SEQRES 15 A 216 ASN PRO GLN HIS PHE ALA CYS LEU LEU GLY ARG LEU THR SEQRES 16 A 216 GLU LEU ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU SEQRES 17 A 216 MET SER TRP ARG VAL ASN ASP HIS SEQRES 1 D 17 SER ASN LEU GLY LEU GLU ASP ILE ILE ARG LYS ALA LEU SEQRES 2 D 17 MET GLY SER PHE SEQRES 1 B 216 GLU LEU THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE SEQRES 2 B 216 MET ASP SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE SEQRES 3 B 216 THR ASN LYS ILE LEU LYS GLU GLU PHE SER ALA GLU GLU SEQRES 4 B 216 ASN PHE LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL SEQRES 5 B 216 GLN VAL LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE SEQRES 6 B 216 GLN THR LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS SEQRES 7 B 216 GLY SER ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU SEQRES 8 B 216 ILE PHE ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU SEQRES 9 B 216 LEU GLU GLU ARG ILE ARG ASN SER GLY ILE SER ASP GLU SEQRES 10 B 216 TYR ILE THR PRO MET PHE SER PHE TYR LYS SER ILE GLY SEQRES 11 B 216 GLU LEU LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR SEQRES 12 B 216 ALA ILE VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS SEQRES 13 B 216 ASP ARG GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU SEQRES 14 B 216 ASP VAL LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU SEQRES 15 B 216 ASN PRO GLN HIS PHE ALA CYS LEU LEU GLY ARG LEU THR SEQRES 16 B 216 GLU LEU ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU SEQRES 17 B 216 MET SER TRP ARG VAL ASN ASP HIS HET FMT A 501 3 HET FMT A 502 3 HET FMT A 503 3 HET FMT A 504 3 HET IVM A 505 62 HET FMT B 501 3 HET FMT B 502 3 HET FMT B 503 3 HET FMT B 504 3 HET IVM B 505 62 HETNAM FMT FORMIC ACID HETNAM IVM (2AE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17AR,20R,20AR, HETNAM 2 IVM 20BS)-6'-[(2S)-BUTAN-2-YL]-20,20B-DIHYDROXY-5',6,8,19- HETNAM 3 IVM TETRAMETHYL-17-OXO-3',4',5',6,6',10,11,14,15,17,17A, HETNAM 4 IVM 20,20A,20B-TETRADECAHYDRO-2H,7H-SPIRO[11,15- HETNAM 5 IVM METHANOFURO[4,3,2-PQ][2,6]BENZODIOXACYCLOOCTADECINE- HETNAM 6 IVM 13,2'-PYRAN]-7-YL 2,6-DIDEOXY-4-O-(2,6-DIDEOXY-3-O- HETNAM 7 IVM METHYL-ALPHA-L-ARABINO-HEXOPYRANOSYL)-3-O-METHYL- HETNAM 8 IVM ALPHA-L-ARABINO-HEXOPYRANOSIDE HETSYN IVM 22,23-DIHYDROAVERMECTIN B1A; IVERMECTIN FORMUL 5 FMT 8(C H2 O2) FORMUL 9 IVM 2(C48 H74 O14) FORMUL 15 HOH *10(H2 O) HELIX 1 1 GLY C 2262 LEU C 2271 1 10 HELIX 2 2 THR A 246 LYS A 262 1 17 HELIX 3 3 GLU A 268 ILE A 273 1 6 HELIX 4 4 ALA A 280 LYS A 304 1 25 HELIX 5 5 HIS A 313 LYS A 339 1 27 HELIX 6 6 LEU A 347 ARG A 351 5 5 HELIX 7 7 TYR A 361 GLU A 374 1 14 HELIX 8 8 THR A 378 LEU A 391 1 14 HELIX 9 9 ASP A 400 GLN A 423 1 24 HELIX 10 10 GLN A 428 HIS A 447 1 20 HELIX 11 11 GLY D 2262 GLY D 2273 1 12 HELIX 12 12 THR B 246 LYS B 262 1 17 HELIX 13 13 ILE B 269 ILE B 273 5 5 HELIX 14 14 ALA B 280 LYS B 304 1 25 HELIX 15 15 GLY B 307 LEU B 311 5 5 HELIX 16 16 ASP B 312 LYS B 338 1 27 HELIX 17 17 SER B 345 ARG B 351 1 7 HELIX 18 18 ILE B 362 LEU B 375 1 14 HELIX 19 19 THR B 378 LEU B 391 1 14 HELIX 20 20 ASP B 400 LYS B 420 1 21 HELIX 21 21 GLN B 428 ASN B 444 1 17 CISPEP 1 LEU C 2261 GLY C 2262 0 -5.37 CISPEP 2 ARG A 264 MET A 265 0 -25.39 CISPEP 3 HIS A 344 SER A 345 0 -5.64 CISPEP 4 SER A 355 GLY A 356 0 -15.81 CISPEP 5 HIS A 447 ALA A 448 0 -13.58 CISPEP 6 SER A 453 TRP A 454 0 -20.39 CISPEP 7 ARG B 264 MET B 265 0 -4.15 CISPEP 8 ALA B 448 GLU B 449 0 5.26 CISPEP 9 SER B 453 TRP B 454 0 -20.82 SITE 1 AC1 2 FMT A 502 FMT A 504 SITE 1 AC2 2 FMT A 501 FMT A 503 SITE 1 AC3 2 ASP A 394 FMT A 502 SITE 1 AC4 3 LEU A 434 FMT A 501 HOH A 601 SITE 1 AC5 14 ARG A 264 LYS A 272 GLU A 276 GLU A 277 SITE 2 AC5 14 ASN A 283 LEU A 287 MET A 290 ASN A 293 SITE 3 AC5 14 ARG A 331 SER A 332 ILE A 335 LEU A 348 SITE 4 AC5 14 TYR A 361 MET A 365 SITE 1 AC6 2 FMT B 502 FMT B 504 SITE 1 AC7 3 FMT B 501 FMT B 503 FMT B 504 SITE 1 AC8 2 ASP B 394 FMT B 502 SITE 1 AC9 2 FMT B 501 FMT B 502 SITE 1 BC1 16 ARG B 264 LYS B 272 GLU B 276 GLU B 277 SITE 2 BC1 16 ASN B 283 LEU B 287 MET B 290 ALA B 291 SITE 3 BC1 16 HIS B 294 ARG B 331 SER B 332 PHE B 336 SITE 4 BC1 16 LEU B 347 ILE B 352 TYR B 361 MET B 365 CRYST1 53.008 161.759 169.018 90.00 90.00 90.00 I 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018865 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005917 0.00000